• About
    • What readers are saying
  • Events
  • Tips
  • Contact
  • Contributors
    • Lisa Suennen
    • Kyle Serikawa
  • In the News
  • Subscribe
Your Edge in Biotech.
  • About
    • What readers are saying
  • Events
  • Tips
  • Contact
  • Contributors
    • Lisa Suennen
    • Kyle Serikawa
  • In the News
  • Subscribe
21
Jul
2015

The Non-Compete Chill Has Passed: Bristol-Myers, MedImmune Settle Over I-O Star

/
Luke Timmerman
/
0
/
All, Cancer, People
21 Jul 2015

This content is available for subscribers of the Timmerman Report.

Subscribe Now

Sign in to your account.

You may also like

Forget Price Controls – Value-Based Pricing is the New Threat to Drug Development
17 Jul 2015
It’s Time to Re-Think Some Assumptions About Cancer R&D
15 Jun 2015
Cancer Combos Force Companies To Do Some Re-Thinking
30 Mar 2015
Ember Therapeutics, After Shutting Down, Pools IP With Mariel
13 Mar 2015

Your account

Sign in

The Timmerman Report Gives You Consistent In-Depth Reporting on Biotechnology. Get Your Edge.

Subscribe today

Already have an account?
Please sign in to your account.

Twitter

  • 2 days ago
  • 3 days ago
  • 10 days ago
  • 25 days ago

Speaking Engagements

I am available to speak about biotech trends at public and private biotech events. See me for details.

Links

See My Writing On Forbes

Listen to My Radio Appearances

Social Network

twitterlinkedin googleplus

Recent Posts

  • Exactly what private yoga teacher won’t require incredible blond spinner Dakota Skye just like the his pupil?
  • You to called for, people montreal nude thing Which words
  • A knowledgeable Homosexual Glucose Daddy Other sites: An entire Book

Topics

  • All
  • Cancer
  • Devices
  • Diagnostics
  • Drugs
  • FDA
  • Finance
  • Genomics
  • People
  • Politics
  • Science
  • Strategy
  • The Edge
  • Tools
  • Venture Capital

© Copyright 2016, TimmermanReport.com
Privacy Policy | Terms of Use
Custom WordPress site by: Perception Builder